NIKKEI 225
27,311.30 +190.80 (+0.70%) HANG SENG
18,012.15 -75.82 (-0.42%) CRUDE OIL
88.47 +0.71 (+0.81%) GOLD FUTURES
1,720.90 +0.10 (+0.01%) DOW
30,005.51 -268.36 (-0.89%) BTC-GBP
17,981.04 -160.54 (-0.88%)
Vaxart, Inc. (VXRT)
- Motley Fool
2 Struggling Stocks to Avoid Right Now
Many companies will rebound from the ongoing downturn as the economy improves, but in all likelihood, many others will continue to struggle. Many rushed to invest in companies such as Canopy Growth, which has long been considered one of the leaders in the field. Cannabis companies had trouble raising funds due to the nature of their business activities.
- Zacks
VAXART, INC. (VXRT) Reports Q2 Loss, Lags Revenue Estimates
VAXART, INC. (VXRT) delivered earnings and revenue surprises of -9.52% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Motley Fool
Could This Unknown Stock Beat Moderna in 2023?
Vaxart (NASDAQ: VXRT) might just be gearing up to steal coronavirus vaccine market share from Moderna (NASDAQ: MRNA) in the next couple of years, making its investors wealthy in the process. The biotech's vaccine tablets could have a few advantages that Moderna's shots don't, including one in particular, that might be a public health holy grail at the moment. For Vaxart's stock to beat Moderna's next year, two things need to happen.
